DR. DEEPAK CHOPRA WITH CYBERHUMAN.AI AND ELEMIND ANNOUNCE PARTNERSHIP TO REVOLUTIONIZE SLEEP

Introducing “21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind”—A New Ritual Combining Guided Meditations and Pioneering Wearable Sleep Technology

NEW YORK, March 10, 2025 /PRNewswire/ — Cyberhuman.ai, founded by world-renowned well-being expert Dr. Deepak Chopra and Poonacha Machaiah, CEO of Cyberhuman.ai, and Elemind Technologies, a leader in neuroscience-based wearable technology, announce a groundbreaking partnership aimed at transforming the way people experience sleep. The collaboration introduces “21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind,” a holistic program that merges Dr. Deepak Chopra’s pre-sleep meditations with Elemind’s pioneering neurotech helping people fall asleep faster, naturally, by directing brainwaves out of wakeful patterns and into a deeper sleep.     

I was an early tester of Elemind and was blown-away by the sleep state it quickly brought me to. Dr. Deepak Chopra

“We are excited to join forces with Elemind Technologies, Inc. to offer an effective approach to achieving restful sleep,” said Dr. Deepak Chopra, Co-Founder of Cyberhuman.ai “I was an early tester of Elemind and was blown-away by the sleep state it quickly brought me to. By combining mindfulness practices with cutting-edge technology, we aim to enhance well-being and vitality on a global scale.”

The “21 Days of Restful Sleep” program is designed to create a ritual that promotes relaxation and rejuvenation. Participants will have access to guided meditations by Dr. Deepak Chopra, paired with Elemind’s sleep on-demand headband that naturally directs the brain from a wakeful state to a restful, sleep state through EEG-tracking and gentle auditory stimulation.  Backed by five years of research, testing and clinical trials, the Elemind headband reads and responds to individual brainwaves in real-time for a personalized approach to sleep.

“Partnering with Cyberhuman.ai allows us to integrate well-being with scientific innovation,” said Meredith Perry, CEO of Elemind. “Dr. Chopra and Elemind are empowering individuals to take charge of their sleep and enhance performance by delivering personalized, accessible solutions for better rest.”

Cyberhuman.ai is a next-gen platform designed to optimize personal health and well-being by delivering AI-driven, personalized programs for peak performance across all areas of life. By leveraging advanced diagnostics and predictive analytics, it provides expert-backed recommendations through a 24/7 virtual well-being assistant.

Elemind Technologies is a neurotech health company elevating health. At the forefront of developing wearable devices that harness neuroscience to improve sleep and performance using non-invasive, wearable neurotech with a breakthrough algorithm that reads and responds to individual brainwaves.

Cyberhuman.ai: Aaron Marion, aaron@marionpr.com

Elemind Technologies: Zoe Weisberg Coady, zoe@brandstyle.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cyberhumanai-and-elemind-technologies-announce-partnership-to-revolutionize-sleep-302397230.html

SOURCE Elemind

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

2 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

11 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

14 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

14 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

14 hours ago